SEC Filings
Government Disclosures
Contracts + Permits
Earnings + IPOs
Treasury Yields
ETF Explorer
Short Volume
Screener
Stock Research
Portfolio Lab
About
Settings
Contact
10-K/A — Day One Biopharmaceuticals, Inc. | Tormere
← 10-K / 10-Q
10-K/A
DAWN
Day One Biopharmaceuticals, Inc.
Filed 2026-04-17
Period ending 2025-12-31
Download to Excel
EDGAR ↗
All periods →
Income Statement
Line Item
2025-12-31
Y/Y
Net Income
-$107.32B
—
